ES345040A2 - New peptides having an acth-activity - Google Patents
New peptides having an acth-activityInfo
- Publication number
- ES345040A2 ES345040A2 ES345040A ES345040A ES345040A2 ES 345040 A2 ES345040 A2 ES 345040A2 ES 345040 A ES345040 A ES 345040A ES 345040 A ES345040 A ES 345040A ES 345040 A2 ES345040 A2 ES 345040A2
- Authority
- ES
- Spain
- Prior art keywords
- boc
- lys
- val
- gly
- pro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Novel peptides which differ from an ACTH- peptide with 18-39 aminoacid residues and an N-terminal L-amino acid in that they contain as N-terminal the residue of D-serine, as the 3rd amino acid glyane and as the 17th and 18th aminoacids L-lysine are prepared by methods known in the peptide art. Intermediates isolated are BOC-D-ser-Fyr-glymet - glu(OtBu) - his - phe - arg - Fry - gly- OH BOC D - ser - Fyr - gly - met - glu(OtBu)- his - phe - arg - Fry - gly - lys (BOC) - pro - valgly - [lys(BOC)] 4 - NH 2 Z - or H - val - Fyrpro - NH 2 Z - or H - lys(BOC) - val - tyr - pro- NH 2 Z- or H-val-lys(BOC)-val-Fyr-pro-NH2 Z- or H-[lys(BOC)]2-pro-val-lys(BOC)-val-Fyrpro-NH 2 Z- or H-lys(BOC).pro-val-gly-[lys- (BOC] 4 - pro - val - lys(BOC) - val - Fyr - pro- NH 2 BOC- or H-tyr-gly-OCH 3 BOC-D-ser- Fyr-gly-OCH 3 or -OH BOC-D-ser-tyr-gly-nle- OCH 3 or -NHNH 2 BOC-D-ser-Fyr-gly-nleglu(OtBu) - his - phe - arg - Fry - gly - OH and BOC - D - ser - Fyr - gly - nle - glu(OtBu) - hisphe - arg - Fry - gly - lys(BOC) - pro - val - [lys- (BOC)] 4 - pro - val - lys(BOC) - val - tyr - pro- OtBu. Pharmaceutical compositions having adrenocorticotropic activity comprise one of the novel peptides together with a suitable carrier for enteral or parenteral application.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1343066 | 1966-09-16 | ||
CH1452666A CH529103A (en) | 1966-09-16 | 1966-10-07 | Process for the production of new peptides with ACTH effects |
CH80467 | 1967-01-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES345040A2 true ES345040A2 (en) | 1968-11-01 |
Family
ID=27172427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES345040A Expired ES345040A2 (en) | 1966-09-16 | 1967-09-14 | New peptides having an acth-activity |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS49183B1 (en) |
AT (1) | AT317448B (en) |
BE (1) | BE703945A (en) |
CH (1) | CH529103A (en) |
DE (1) | DE1643274B2 (en) |
ES (1) | ES345040A2 (en) |
FR (1) | FR7816M (en) |
GB (1) | GB1203301A (en) |
NL (1) | NL143552B (en) |
SE (1) | SE359822B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5072774U (en) * | 1973-11-10 | 1975-06-26 |
-
1966
- 1966-10-07 CH CH1452666A patent/CH529103A/en not_active IP Right Cessation
-
1967
- 1967-09-07 DE DE1967C0043292 patent/DE1643274B2/en active Granted
- 1967-09-14 ES ES345040A patent/ES345040A2/en not_active Expired
- 1967-09-15 NL NL6712664A patent/NL143552B/en unknown
- 1967-09-15 BE BE703945D patent/BE703945A/xx not_active Expired
- 1967-09-15 SE SE1273567A patent/SE359822B/xx unknown
- 1967-09-15 AT AT08451/67A patent/AT317448B/en not_active IP Right Cessation
- 1967-09-16 JP JP42059106A patent/JPS49183B1/ja active Pending
- 1967-09-18 GB GB4160667A patent/GB1203301A/en not_active Expired
- 1967-12-12 FR FR131867A patent/FR7816M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
SE359822B (en) | 1973-09-10 |
DE1643274B2 (en) | 1976-07-22 |
DE1643274A1 (en) | 1971-07-29 |
NL6712664A (en) | 1968-03-18 |
NL143552B (en) | 1974-10-15 |
FR7816M (en) | 1970-05-20 |
GB1203301A (en) | 1970-08-26 |
BE703945A (en) | 1968-03-15 |
CH529103A (en) | 1972-10-15 |
JPS49183B1 (en) | 1974-01-05 |
AT317448B (en) | 1974-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8101585L (en) | NUTRITION COMPOSITION, AS WELL AS ITS ADMINISTRATION | |
GB1498048A (en) | Decapeptide amides | |
DE3066654D1 (en) | Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use | |
DE68927379T2 (en) | SLIDE BLOCKING PEPTIDES | |
AU472647B2 (en) | N-protected amino acids and peptides | |
JPS5594934A (en) | Peptide type polymer and pharmaceutic composition containing it | |
ES345040A2 (en) | New peptides having an acth-activity | |
MX167236B (en) | SYNTHETIC PEPTIDES OF THYMOSINE -1 AND METHOD FOR OBTAINING THEM | |
GB1309150A (en) | Acthactive peptides and process for their manufacture | |
ES434673A1 (en) | Solid phase synthesis of ACTH | |
GB1536878A (en) | Octapeptide | |
GR3017297T3 (en) | Novel substrate peptides. | |
ES316390A1 (en) | Peptides having an adrenocorticotropic hormone action and process for their manufacture | |
GB1342803A (en) | Psychopharmacological preparation | |
ES418158A1 (en) | Peptides of acth activity containing alpha-aminooxy carboxylic acids on both terminals and a process for the preparation thereof | |
GB1437477A (en) | Synthetic peptides | |
GB1298318A (en) | Corticotropin peptides | |
GB1353827A (en) | Acthaction peptides and process for their manufacture | |
GB1287125A (en) | New peptides and process for their manufacture | |
GB992957A (en) | New decapeptides and their manufacture | |
GB1516725A (en) | Polypeptides having acth-like action | |
GB1231494A (en) | ||
ES421641A1 (en) | Procedure for the preparation of a biologically active peptide of the human parathyroid hormone. (Machine-translation by Google Translate, not legally binding) | |
GB1210551A (en) | New peptides having an acth-activity and process for their manufacture | |
ES417951A1 (en) | Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof |